Robert J Young

17PUBLICATIONS
44CO-AUTHORS
Innate immunityBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesSolution chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo.

|Feb 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead.

Jean Quancard, Anders Bach, Chiara Borsari

|Dec 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.

Ross P Hryczanek, Andrew S Hackett, Paul Rowland

|Oct 21, 2024
A compound-target pairs dataset: differences between drugs, clinical candidates and other bioactive compounds.

A Lina Heinzke, Barbara Zdrazil, Paul D Leeson

|Jun 28, 2023
Today's drug discovery and the shadow of the rule of 5.

Robert J Young

|Dec 05, 2022
The Time and Place for Nature in Drug Discovery.

Robert J Young, Sabine L Flitsch, Michael Grigalunas

Pageof 3

Frequent Collaborators

4 joint publications

Christopher P Tinworth

3 joint publications

Paul D Leeson

3 joint publications

Efstratios Stratikos

2 joint publications

Barbara Zdrazil